Indole Compounds for Selective Senescent Cell Elimination

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Skin aging is a complex process characterized by dryness, fine lines, wrinkles, uneven pigmentation, loss of elasticity, and sagging, accelerated by extrinsic factors, and current cosmetic products lack effective interventions targeting senescent skin cells, which drive the aging phenotype.

Innovation Solution

The use of indole compounds, specifically those corresponding to general formula (I), for the selective elimination of senescent skin cells, incorporated into topical compositions to treat signs of skin aging by reducing or eliminating characteristics such as thin and dry skin, fine wrinkles, and decreased elasticity.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Reliability

If conventional cosmetic products are used to treat skin aging, then general skin care needs are addressed, but they lack effective intervention against senescent skin cells which drive the aging phenotype

Engineering Contradiction:
Improveeffectiveness against senescent cellsVSAvoidtargeting capability
Core Design Contradiction:
ReliabilityVSAdaptability or versatility

Solution Approach 1:

The patent changes the chemical parameter by introducing indole compounds with specific molecular structures (formula I) that have senolytic activity. These compounds selectively target senescent cells through their unique chemical properties, transforming the approach from general skin care to targeted senescent cell elimination, thereby resolving the contradiction between reliability against senescent cells and adaptability for specific targeting

Inventive Principle:
Principle #35Parameter changes

2Shape

If topical compositions are applied to treat skin aging signs, then visible improvements are achieved, but the underlying senescent cells remain untreated

Engineering Contradiction:
Improveskin appearanceVSAvoidcellular level intervention
Core Design Contradiction:
ShapeVSReliability

Solution Approach 1:

The patent applies preliminary action by eliminating senescent cells before they can continue to drive the aging phenotype. The indole compounds in the topical composition selectively kill senescent dermal fibroblasts first, preventing further aging damage, which then leads to improved skin appearance. This reverses the conventional approach of treating appearance symptoms after they manifest

Inventive Principle:
Principle #10Preliminary action

3Reliability

If senescent skin cells are selectively eliminated, then skin aging signs are reduced, but the complexity of identifying and targeting these cells increases

Engineering Contradiction:
Improveaging treatment efficacyVSAvoidtargeting mechanism
Core Design Contradiction:
ReliabilityVSDevice complexity

Solution Approach 1:

The patent applies self-service by designing indole compounds that automatically recognize and selectively target senescent cells through their inherent molecular properties. The compounds exploit the unique characteristics of senescent cells (such as altered membrane composition or metabolic state) to achieve selective elimination without requiring complex external targeting systems, thus maintaining simplicity while achieving high reliability

Inventive Principle:
Principle #25Self-service

Data Source

PatentEP4168130B1Use of indole compounds for treating signs of skin aging
Publication Date: 2025.03.26 UNILEVER IP HLDG BV
  • EP4168130B1 patent drawing
  • EP4168130B1 patent drawing
  • EP4168130B1 patent drawing

AI summary

The invention provides the use of one or more indole compounds corresponding to general formula (I) in which Z is a divalent aliphatic hydrocarbon radical and M is hydrogen or a salt-forming cation; for treating signs of skin aging.